Referral lab - cancer testing
Ended Awarded Last action
- Contract number
- W91YTZ23F0208
- Awardee
-
Exact Sciences Corporation UEI NGBXEJX5GLE9
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $96,711
Award facts
- Contract value 100% obligated
- $96,710.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Liberty, NC 28310, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $96,711 |
About this award
Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a $96,710.88 firm fixed-price blanket purchase agreement call by the Defense Health Agency for referral laboratory cancer testing services. The contract, which commenced on September 18, 2023, with an ultimate completion date of September 17, 2024, will be performed at Fort Liberty, North Carolina. This award operates under the Medical Laboratory Testing and Analysis Services (FSS-621-II) General Services Administration Federal Supply Schedule, a governmentwide acquisition contract vehicle that streamlines federal procurement of specialized medical laboratory services. The contract was awarded without set-aside designations, reflecting Exact Sciences' competitive position as a specialized provider of proprietary diagnostic oncology services.
Exact Sciences Corporation is a leading medical technology company headquartered in Madison, Wisconsin, specializing in advanced diagnostic testing for cancer screening, detection, and treatment planning. The company's primary service offering consists of Oncotype DX gene expression profiling assays, which analyze mRNA expression to assess cancer recurrence risk and predict treatment responsiveness across multiple cancer types. The Defense Health Agency maintains a broader $5 million blanket purchase agreement with the company for oncology prostate testing services and a $463,098 agreement for cancer testing referral laboratory services through August 2026, demonstrating sustained federal demand for Exact Sciences' specialized oncology diagnostic capabilities across the Department of Defense medical systems.
Quick answers
Who was awarded contract W91YTZ23F0208?
W91YTZ23F0208 was awarded to Exact Sciences Corporation by Medical Command (Department of the Army) on September 18, 2023.
How much is contract W91YTZ23F0208 worth?
The government has obligated $96,711 on W91YTZ23F0208.
Which agency awarded contract W91YTZ23F0208?
Medical Command (Department of the Army) awarded W91YTZ23F0208, with funding from Defense Health Agency (Department of Defense).
Is contract W91YTZ23F0208 an order under another contract?
Yes. W91YTZ23F0208 is a BPA call under V797D70053-W91YTZ21A0010, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract W91YTZ23F0208 competed?
The extent of competition for W91YTZ23F0208 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award